Application of hematopoietic stem cell transplantation in the treatment of primary myelofibrosis / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 314-317, 2016.
Article
en Zh
| WPRIM
| ID: wpr-492982
Biblioteca responsable:
WPRO
ABSTRACT
Drugs and symptomatic and supportive treatment are still the main treatment in the primary myelofibrosis (PMF),but they can only improve symptoms without the natural course change of PMF.Hematopoietic stem cell transplantation (HSCT) is the only curable means to PMF,however,serious transplantrelated complications limit its extensive application in PMF patients.In this paper,donor selection process,pretreatment,successful transplantation factors and other factors on HSCT in PMF patients will be reviewed.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Journal of Leukemia & Lymphoma
Año:
2016
Tipo del documento:
Article